EGFR and non-small cell lung carcinoma: In EGFR‐mutated NSCLC cell lines, shRNA‐mediated knockdown of ARID1A promoted cell cycle activation, ErbB pathway activation, VEGF pathway activation, and expression of epithelial‐mesenchymal transformation (EMT) genes [43].